ID   HYAL1_MOUSE             Reviewed;         462 AA.
AC   Q91ZJ9; B1AV90; O70229; Q8CE62; Q8QZX3; Q8VBW7; Q8VDK0;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   07-APR-2021, entry version 147.
DE   RecName: Full=Hyaluronidase-1;
DE            Short=Hyal-1;
DE            EC=3.2.1.35;
DE   AltName: Full=Hyaluronoglucosaminidase-1;
DE   Flags: Precursor;
GN   Name=Hyal1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9503017; DOI=10.1006/geno.1997.5158;
RA   Csoka A.B., Frost G.I., Heng H.H.Q., Scherer S.W., Mohapatra G., Stern R.;
RT   "The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and
RT   9F1-F2 in mouse, a conserved candidate tumor suppressor locus.";
RL   Genomics 48:63-70(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   STRAIN=C3H/HeJ;
RX   PubMed=11960552; DOI=10.1186/1471-2121-3-8;
RA   Chang N.-S.;
RT   "Transforming growth factor-beta1 blocks the enhancement of tumor necrosis
RT   factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.";
RL   BMC Cell Biol. 3:8-8(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Csoka A.B.;
RT   "Genomic sequence of the mouse Hyal1 locus encoding the mouse Hyal1, Fus2,
RT   and Hyal3 genes.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Skin;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=Czech II; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 331-462, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=129/Sv;
RX   PubMed=11929860; DOI=10.1074/jbc.m108991200;
RA   Shuttleworth T.L., Wilson M.D., Wicklow B.A., Wilkins J.A.,
RA   Triggs-Raine B.L.;
RT   "Characterization of the murine hyaluronidase gene region reveals complex
RT   organization and cotranscription of Hyal1 with downstream genes, Fus2 and
RT   Hyal3.";
RL   J. Biol. Chem. 277:23008-23018(2002).
CC   -!- FUNCTION: May have a role in promoting tumor progression. May block the
CC       TGFB1-enhanced cell growth. {ECO:0000269|PubMed:11960552}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Random hydrolysis of (1->4)-linkages between N-acetyl-beta-D-
CC         glucosamine and D-glucuronate residues in hyaluronate.; EC=3.2.1.35;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 3.5-4.0. {ECO:0000269|PubMed:9503017};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Lysosome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q91ZJ9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q91ZJ9-2; Sequence=VSP_015923;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver, kidney, lung and skin.
CC       {ECO:0000269|PubMed:11929860, ECO:0000269|PubMed:9503017}.
CC   -!- DEVELOPMENTAL STAGE: Detected in embryos of all developmental stages,
CC       with high level at the 7 day stage. {ECO:0000269|PubMed:11929860}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 56 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF011567; AAC15949.1; -; mRNA.
DR   EMBL; AF422176; AAL17822.1; -; mRNA.
DR   EMBL; AF069741; AAL54881.1; -; Genomic_DNA.
DR   EMBL; AF338323; AAL57173.1; -; Genomic_DNA.
DR   EMBL; AK028942; BAC26206.1; -; mRNA.
DR   EMBL; AL672219; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021636; AAH21636.1; -; mRNA.
DR   EMBL; AF417496; AAM14428.1; -; mRNA.
DR   EMBL; AF417497; AAM14430.1; -; mRNA.
DR   EMBL; AF417498; AAM14432.1; -; mRNA.
DR   RefSeq; NP_001318090.1; NM_001331161.1.
DR   RefSeq; NP_032343.2; NM_008317.5.
DR   SMR; Q91ZJ9; -.
DR   STRING; 10090.ENSMUSP00000010195; -.
DR   CAZy; GH56; Glycoside Hydrolase Family 56.
DR   GlyGen; Q91ZJ9; 5 sites.
DR   PhosphoSitePlus; Q91ZJ9; -.
DR   PaxDb; Q91ZJ9; -.
DR   PRIDE; Q91ZJ9; -.
DR   ProteomicsDB; 273061; -. [Q91ZJ9-1]
DR   ProteomicsDB; 273062; -. [Q91ZJ9-2]
DR   Antibodypedia; 1046; 283 antibodies.
DR   Ensembl; ENSMUST00000010195; ENSMUSP00000010195; ENSMUSG00000010051. [Q91ZJ9-1]
DR   Ensembl; ENSMUST00000112387; ENSMUSP00000108006; ENSMUSG00000010051. [Q91ZJ9-2]
DR   GeneID; 15586; -.
DR   KEGG; mmu:15586; -.
DR   UCSC; uc009rlv.1; mouse. [Q91ZJ9-1]
DR   UCSC; uc009rlw.1; mouse. [Q91ZJ9-2]
DR   CTD; 3373; -.
DR   MGI; MGI:96298; Hyal1.
DR   eggNOG; ENOG502QTUU; Eukaryota.
DR   GeneTree; ENSGT01020000230364; -.
DR   HOGENOM; CLU_036366_0_0_1; -.
DR   InParanoid; Q91ZJ9; -.
DR   OMA; GQCPLGI; -.
DR   OrthoDB; 1096692at2759; -.
DR   TreeFam; TF321598; -.
DR   Reactome; R-MMU-2024101; CS/DS degradation.
DR   Reactome; R-MMU-2160916; Hyaluronan uptake and degradation.
DR   BioGRID-ORCS; 15586; 1 hit in 54 CRISPR screens.
DR   ChiTaRS; Hyal1; mouse.
DR   PRO; PR:Q91ZJ9; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q91ZJ9; protein.
DR   Bgee; ENSMUSG00000010051; Expressed in liver and 57 other tissues.
DR   ExpressionAtlas; Q91ZJ9; baseline and differential.
DR   Genevisible; Q91ZJ9; MM.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0036117; C:hyaluranon cable; ISS:UniProtKB.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0050501; F:hyaluronan synthase activity; ISS:UniProtKB.
DR   GO; GO:0004415; F:hyalurononglucosaminidase activity; ISS:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0051216; P:cartilage development; ISS:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISO:MGI.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISS:UniProtKB.
DR   GO; GO:0071467; P:cellular response to pH; ISS:UniProtKB.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0071493; P:cellular response to UV-B; ISS:UniProtKB.
DR   GO; GO:0060272; P:embryonic skeletal joint morphogenesis; IMP:MGI.
DR   GO; GO:0030213; P:hyaluronan biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0030214; P:hyaluronan catabolic process; ISS:UniProtKB.
DR   GO; GO:0030212; P:hyaluronan metabolic process; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISS:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0045927; P:positive regulation of growth; ISS:UniProtKB.
DR   GO; GO:1900106; P:positive regulation of hyaluranon cable assembly; ISS:UniProtKB.
DR   GO; GO:0046677; P:response to antibiotic; ISS:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; ISS:UniProtKB.
DR   GO; GO:0009615; P:response to virus; IDA:UniProtKB.
DR   GO; GO:0046718; P:viral entry into host cell; IEA:GOC.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR018155; Hyaluronidase.
DR   PANTHER; PTHR11769; PTHR11769; 1.
DR   Pfam; PF01630; Glyco_hydro_56; 1.
DR   PIRSF; PIRSF038193; Hyaluronidase; 1.
DR   PRINTS; PR00846; GLHYDRLASE56.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; EGF-like domain; Glycoprotein;
KW   Glycosidase; Hydrolase; Lysosome; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..52
FT                   /evidence="ECO:0000255"
FT   CHAIN           53..462
FT                   /note="Hyaluronidase-1"
FT                   /id="PRO_0000042624"
FT   DOMAIN          446..457
FT                   /note="EGF-like"
FT   ACT_SITE        159
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        127
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        244
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        265
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        378
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        71..361
FT                   /evidence="ECO:0000250"
FT   DISULFID        235..249
FT                   /evidence="ECO:0000250"
FT   DISULFID        386..397
FT                   /evidence="ECO:0000250"
FT   DISULFID        391..446
FT                   /evidence="ECO:0000250"
FT   DISULFID        448..457
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         455..462
FT                   /note="KWCDKRGM -> GSST (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015923"
FT   CONFLICT        16
FT                   /note="P -> S (in Ref. 1; AAC15949 and 2; AAL17822)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="G -> R (in Ref. 1; AAC15949)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        284
FT                   /note="E -> G (in Ref. 2; AAL17822 and 3; AAL54881/
FT                   AAL57173)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        450
FT                   /note="R -> C (in Ref. 2; AAL17822 and 3; AAL54881/
FT                   AAL57173)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   462 AA;  52109 MW;  DCE7339D7E0BCB9D CRC64;
     MLGLTQHAQK VWRMKPFSPE VSPGSSPATA GHLLRISTLF LTLLELAQVC RGSVVSNRPF
     ITVWNGDTHW CLTEYGVDVD VSVFDVVANK EQSFQGSNMT IFYREELGTY PYYTPTGEPV
     FGGLPQNASL VTHLAHTFQD IKAAMPEPDF SGLAVIDWEA WRPRWAFNWD SKDIYRQRSM
     ELVQAEHPDW PETLVEAAAK NQFQEAAEAW MAGTLQLGQV LRPRGLWGYY GFPDCYNNDF
     LSLNYTGQCP VFVRDQNDQL GWLWNQSYAL YPSIYLPAAL MGTEKSQMYV RHRVQEALRV
     AIVSRDPHVP VMPYVQIFYE MTDYLLPLEE LEHSLGESAA QGVAGAVLWL SSDKTSTKES
     CQAIKAYMDS TLGPFIVNVT SAALLCSEAL CSGHGRCVRH PSYPEALLTL NPASFSIELT
     HDGRPPSLKG TLSLKDRAQM AMKFRCRCYR GWRGKWCDKR GM
//
